Application of the new cholesterol guidelines

New England Journal of Medicine

Volumn 371, Issue 1, 2014, Pages 77-79

  Gallegos Villalobos, Angel ^a   Portolés, José ^b   Ortiz, Alberto ^a  

^a Instituto de Investigación Sanitaria Fundación Jiménez Díaz   (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DE HIERRO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CHOLESTEROL BLOOD LEVEL; HUMAN; INTERNATIONAL COOPERATION; LETTER; NUTRITIONAL ASSESSMENT; PHYSICIAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH; STRATEGIC PLANNING; TREATMENT PLANNING; UNITED STATES;

CARDIOVASCULAR DISEASES; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; HYPERCHOLESTEROLEMIA; MALE; PRACTICE GUIDELINES AS TOPIC;

EID: 84903700160     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1405680     Document Type: Letter

References (5)

1. Pencina MJ, Navar-Boggan AM, D'Agostino RB, et al. Application of new cholesterol guidelines to a population-based sample. N Engl J Med 2014;370:1422-31.
2. Tonelli M, Wanner C, Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group Members. Lipid management in chronic kidney disease: synopsis of the Kidney Disease: Improving Global Outcomes 2013 clinical practice guideline. Ann Intern Med 2014;160:182.
3. Vademecum from Spain, presenting official, government-approved price in an EU country (http://www.vademecum.es).
4. Howden LM, Meyer JA. Age and sex composition: 2010. 2010 Census briefs. Washington, DC: Department of Commerce Economics and Statistics Administration, May 2011 (http://www.census.gov/prod/cen2010/briefs/c2010br-03.pdf).
5. Stevens LA, Li S, Wang C, et al. Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP). Am J Kidney Dis 2010;55:Suppl 2:S23-S33.